Literature DB >> 15890936

Varicella-zoster virus ORF4 latency-associated protein is important for establishment of latency.

Jeffrey I Cohen1, Tammy Krogmann, Jeffrey P Ross, Lesley Pesnicak, Elena A Prikhod'ko.   

Abstract

Varicella-zoster virus (VZV) encodes at least six genes that are expressed during latency. One of the genes, ORF4, encodes an immediate-early protein that is present in the virion tegument. ORF4 RNA and protein have been detected in latently infected human ganglia. We have constructed a VZV mutant deleted for ORF4 and have shown that the gene is essential for replication in vitro. The ORF4 mutant virus could be propagated when grown in cells infected with baculovirus expressing the ORF4 protein under the human cytomegalovirus immediate-early promoter. In contrast, the VZV ORF4 deletion mutant could not be complemented in cells expressing herpes simplex virus type 1 (HSV-1) ICP27, the homolog of ORF4. Cells infected with baculovirus expressing ORF4 did not complement an HSV-1 ICP27 deletion mutant. VZV-infected cotton rats have been used as a model for latency; viral DNA and latency-associated transcripts are expressed in dorsal root ganglia 1 month or more after experimental infection. Cotton rats inoculated with VZV lacking ORF4 showed reduced frequency of latency compared to animals infected with the parental or ORF4-rescued virus. Thus, in addition to VZV ORF63, which was previously shown to be critical for efficient establishment of latency, ORF4 is also important for latent infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15890936      PMCID: PMC1112154          DOI: 10.1128/JVI.79.11.6969-6975.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Association of ICP0 but not ICP27 with purified virions of herpes simplex virus type 1.

Authors:  F Yao; R J Courtney
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

2.  Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons.

Authors:  R Mahalingam; M Wellish; R Cohrs; S Debrus; J Piette; B Rentier; D H Gilden
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

3.  Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase.

Authors:  T I Ng; L Keenan; P R Kinchington; C Grose
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

4.  Varicella-zoster virus open reading frame 4 protein is functionally distinct from and does not complement its herpes simplex virus type 1 homolog, ICP27.

Authors:  H Moriuchi; M Moriuchi; H A Smith; J I Cohen
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

5.  Regulation of varicella-zoster virus gene expression in human T lymphocytes.

Authors:  L P Perera; J D Mosca; W T Ruyechan; J Hay
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

6.  Varicella-zoster virus open reading frame 1 encodes a membrane protein that is dispensable for growth of VZV in vitro.

Authors:  J I Cohen; K E Seidel
Journal:  Virology       Date:  1995-02-01       Impact factor: 3.616

7.  The transcriptional regulatory proteins encoded by varicella-zoster virus open reading frames (ORFs) 4 and 63, but not ORF 61, are associated with purified virus particles.

Authors:  P R Kinchington; D Bookey; S E Turse
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

8.  Characterization of the regulatory functions of varicella-zoster virus open reading frame 4 gene product.

Authors:  P Defechereux; L Melen; L Baudoux; M P Merville-Louis; B Rentier; J Piette
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

9.  Varicella-zoster virus latency in the adult rat is a useful model for human latent infection.

Authors:  C Sadzot-Delvaux; S Debrus; A Nikkels; J Piette; B Rentier
Journal:  Neurology       Date:  1995-12       Impact factor: 9.910

10.  Varicella-zoster virus open reading frame 4 encodes a transcriptional activator that is functionally distinct from that of herpes simplex virus homology ICP27.

Authors:  L P Perera; S Kaushal; P R Kinchington; J D Mosca; G S Hayward; S E Straus
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more
  25 in total

1.  Differentiated neuroblastoma cells provide a highly efficient model for studies of productive varicella-zoster virus infection of neuronal cells.

Authors:  Jenna Christensen; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Negative autoregulation of Epstein-Barr virus (EBV) replicative gene expression by EBV SM protein.

Authors:  Dinesh Verma; Chen Ling; Eric Johannsen; Tirumuru Nagaraja; Sankar Swaminathan
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

Review 3.  Herpes zoster and the search for an effective vaccine.

Authors:  N Arnold; I Messaoudi
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

4.  Granzyme B Cleaves Multiple Herpes Simplex Virus 1 and Varicella-Zoster Virus (VZV) Gene Products, and VZV ORF4 Inhibits Natural Killer Cell Cytotoxicity.

Authors:  Chelsea Gerada; Megan Steain; Tessa Mollie Campbell; Brian McSharry; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

5.  A varicella-zoster virus mutant impaired for latency in rodents, but not impaired for replication in cell culture.

Authors:  Aruna P N Ambagala; Tammy Krogmann; Jing Qin; Lesley Pesnicak; Jeffrey I Cohen
Journal:  Virology       Date:  2010-02-08       Impact factor: 3.616

6.  Cell-based screening assay for antiviral compounds targeting the ability of herpesvirus posttranscriptional regulatory proteins to stabilize viral mRNAs.

Authors:  Dinesh Verma; Eun A Kim; Sankar Swaminathan
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

7.  A systematic approach for the identification of novel, serologically reactive recombinant Varicella-Zoster Virus (VZV) antigens.

Authors:  Maria G Vizoso Pinto; Klaus-Ingmar Pfrepper; Tobias Janke; Christina Noelting; Michaela Sander; Angelika Lueking; Juergen Haas; Hans Nitschko; Gundula Jaeger; Armin Baiker
Journal:  Virol J       Date:  2010-07-20       Impact factor: 4.099

8.  Multiple roles of Epstein-Barr virus SM protein in lytic replication.

Authors:  Zhao Han; Elessa Marendy; Yong-Dong Wang; Jing Yuan; Jeffery T Sample; Sankar Swaminathan
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

9.  A highly efficient protocol of generating and analyzing VZV ORF deletion mutants based on a newly developed luciferase VZV BAC system.

Authors:  Zhen Zhang; Ying Huang; Hua Zhu
Journal:  J Virol Methods       Date:  2008-01-22       Impact factor: 2.014

10.  Varicella-zoster virus IE4 protein interacts with SR proteins and exports mRNAs through the TAP/NXF1 pathway.

Authors:  Isabelle Ote; Marielle Lebrun; Patricia Vandevenne; Sébastien Bontems; Cahora Medina-Palazon; Evelyne Manet; Jacques Piette; Catherine Sadzot-Delvaux
Journal:  PLoS One       Date:  2009-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.